Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mesquite, TX
NPI
1215191754
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1621 N Belt Line Rd Ste A
Mesquite, TX, 75149
Phone (972) 682-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
2,731 services
Medicare patients, 2024
204
Average age 70
Drug cost, 2024
$2.6M
6,470 prescriptions
Company payments, 2025
$2,828
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shalini Paturi was code J0897 (injection, denosumab, 1 mg), 1,380 times for 14 patients. In total Shalini Paturi billed 2,731 services in 29 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 14 | $20.61 | $28K |
| 99214 Office E&M - Established | Office | 482 | 190 | $88.75 | $43K |
| 82947 Clinical Chemistry | Office | 184 | 81 | $3.79 | $697 |
| 95251 Test - Miscellaneous | Office | 178 | 57 | $25.54 | $4,545 |
| 95923 Electrical Nerve Conductivity | Office | 65 | 57 | $90.41 | $5,877 |
| 95924 Electrical Nerve Conductivity | Office | 56 | 50 | $111.05 | $6,219 |
| 93923 Duplex Scan - Extremity Arteries | Office | 54 | 48 | $101.44 | $5,478 |
| 93040 Electrocardiogram | Office | 54 | 48 | $9.99 | $539 |
| 99213 Office E&M - Established | Office | 51 | 45 | $64.14 | $3,271 |
| 76536 Ultrasound - Nonspecific | Office | 43 | 40 | $80.04 | $3,442 |
| 96372 Injection Administration | Office | 37 | 19 | $9.73 | $360 |
| 99204 Office E&M - New | Office | 31 | 31 | $112.24 | $3,480 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 29 | $10.96 | $318 |
By year: 2022 $97K for 4,422 services; 2023 $107K for 2,644 services; 2024 $112K for 2,731 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 184 | 81 | $3.79 | $697 |
Medicare prescription drug claims, 2024
In 2024, the drug Shalini Paturi prescribed most often to Medicare patients was Levothyroxine Sodium, with 902 prescriptions and refills. In total Shalini Paturi wrote 6,470 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 902 | 1,814 | 201 | $5,298 |
| Ozempic Semaglutide | 547 | 755 | 119 | $697K |
| Mounjaro Tirzepatide | 350 | 423 | 63 | $446K |
| Jardiance Empagliflozin | 255 | 391 | 62 | $229K |
| Methimazole Generic | 249 | 379 | 44 | $1,767 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 193 | 370 | 73 | $20K |
| Tresiba Flextouch U-100 Insulin Degludec | 173 | 267 | 59 | $133K |
| Humalog Kwikpen U-100 Insulin Lispro | 149 | 222 | 53 | $51K |
| Rosuvastatin Calcium Generic | 147 | 328 | 46 | $1,613 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 137 | 279 | 45 | $1,275 |
| Metformin Hcl Er Metformin Hcl | 131 | 255 | 38 | $914 |
| Metformin Hcl Generic | 123 | 274 | 39 | $727 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 119 | 188 | 38 | $17K |
| Pregabalin Generic | 118 | 203 | 37 | $2,949 |
| Repaglinide Generic | 113 | 166 | 34 | $1,896 |
Brand drugs: 3,352 claims; generic drugs: 2,605 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shalini Paturi $2,828 ($2,828 in general payments such as food, travel and fees) from 28 companies. The largest payer was Amgen Inc. with $309.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 18 | $309 |
| Novo Nordisk Inc NVO | 13 | $289 |
| Madrigal Pharmaceuticals MDGL | 13 | $223 |
| Mannkind Corporation MNKD | 15 | $200 |
| Medtronic, Inc. MDT | 7 | $178 |
| Abbott Laboratories ABT | 8 | $170 |
| Lilly USA, LLC LLY | 9 | $144 |
| Tandem Diabetes Care, Inc. TNDM | 8 | $140 |
| Xeris Pharmaceuticals, Inc. | 9 | $135 |
| Corcept Therapeutics CORT | 4 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.